QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ZoetisVertex PharmaceuticalsBayer AktiengesellschaftRegeneron PharmaceuticalsTakeda Pharmaceutical
SymbolNYSE:ZTSNASDAQ:VRTXOTCMKTS:BAYRYNASDAQ:REGNNYSE:TAK
Price Information
Current Price$157.20$212.88$15.82$455.19$17.31
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score2.12.41.02.62.0
Analysis Score1.34.40.04.43.5
Community Score3.23.22.32.62.1
Dividend Score1.70.02.50.03.3
Ownership Score3.31.70.01.70.0
Earnings & Valuation Score1.32.50.04.41.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$167.73$291.85N/A$625.81$30.00
% Upside from Price Target6.70% upside37.09% upsideN/A37.48% upside73.31% upside
Trade Information
Market Cap$74.93 billion$54.69 billion$59.00 billion$49.61 billion$53.53 billion
Beta0.710.791.340.31.01
Average Volume1,936,2482,197,294553,7281,105,9234,593,394
Sales & Book Value
Annual Revenue$6.26 billion$4.16 billion$48.23 billion$7.86 billion$30.20 billion
Price / Sales11.9313.291.226.201.81
Cashflow$4.47 per share$4.60 per share$3.48 per share$21.53 per share$3.31 per share
Price / Cash35.1746.274.5521.145.23
Book Value$5.69 per share$23.66 per share$14.27 per share$100.56 per share$13.80 per share
Price / Book27.639.001.114.531.25
Profitability
Net Income$1.50 billion$1.18 billion$4.58 billion$2.12 billion$407.02 million
EPS$3.64$4.29$1.77$21.47$1.78
Trailing P/E Ratio46.6526.88N/A16.6457.70
Forward P/E Ratio38.1622.918.2413.427.90
P/E Growth4.351.256.100.82N/A
Net Margins25.50%38.51%-22.32%38.28%3.04%
Return on Equity (ROE)63.89%28.55%14.23%28.97%13.46%
Return on Assets (ROA)14.99%20.68%5.01%20.11%5.02%
Dividend
Annual Payout$1.00N/A$0.53N/A$0.72
Dividend Yield0.64%N/A3.35%N/A4.16%
Three-Year Dividend GrowthN/AN/AN/AN/A6.41%
Payout Ratio27.47%N/A29.94%N/A40.45%
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.41%0.07%1.12%0.27%0.99%
Current Ratio3.47%3.72%1.10%3.89%1.51%
Quick Ratio2.60%3.60%0.81%3.12%1.08%
Ownership Information
Institutional Ownership Percentage92.50%92.17%N/A85.00%3.41%
Insider Ownership Percentage0.17%0.70%N/A11.84%N/A
Miscellaneous
Employees10,6003,000100,6188,31447,495
Shares Outstanding475.17 million259.96 million3.73 billion107.13 million3.15 billion
Next Earnings Date5/5/2021 (Estimated)5/5/2021 (Estimated)4/26/2021 (Estimated)5/4/2021 (Estimated)5/12/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.